Patent Assignment
Reel/Frame 016470/0610
Change of Name
Recorded: 2005-08-31
Pages: 2
Assignor
ASTA PHARMA AKTIENGESELLSCHAFT
Executed: 1995-02-24
Assignee
ASTA MEDICA AKTIENGESELLSCHAFT
X, DRESDEN, GERMANY
Covered Properties
(4)
Azelastine and Its Salts Used to Combat Psoriasis
Patent:
5,110,814 →
Application:
07/458,350 →
Azelastine Embonate and Compositions Which Contain It
Patent:
5,232,919 →
Application:
07/598,742 →
Method of Treating Inflammatory Disorders and Psoriasis with Salts of Azelastine
Patent:
5,086,050 →
Application:
07/652,986 →
Controlled Release Azelastine-Containing Pharmaceutical Compositions
Patent:
5,271,946 →
Application:
07/865,769 →
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 10, 2002
From: VIATRIS GMBH & CO. KG
To: MEDPOINTE HEALTHCARE, INC.
Reel/Frame 013269/0141 →
Change of Name
Oct 21, 2002
From: ASTA MEDICA AG
To: VIATRIS GMBH & CO. KG
Reel/Frame 013386/0851 →
Security Interest
Oct 8, 2003
From: MEDPOINTE INC.; MCC ACQUISITION SUB CORPORATION; MCC MERGER SUB CORPORATION
To: LEHMAN COMMERCIAL PAPER, INC.
Reel/Frame 014567/0804 →
Corrective Assignment to Correct the Patent Number from 5,232,219 Previously Recorded on Reel 016470 Frame 0610. Assignor(S) Hereby Confirms the Correct Patent Number Is 5,232,919.
Sep 1, 2005
From: ASTA PHARMA AKTIENGESELLSCHAFT
To: ASTA MEDICA AKTIENGESELLSCHAFT
Reel/Frame 016480/0246 →
Release of Security Interest
May 25, 2006
From: LEHMAN COMMERICAL PAPER INC.
To: MEDPOINTE HEALTHCARE INC.
Reel/Frame 017675/0384 →
Security Agreement
Jun 6, 2006
From: MEDPOINTE HEALTHCARE INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 017730/0008 →
Change of Name
Jul 22, 2008
From: MEDPOINTE HEALTHCARE INC.
To: MEDA PHARMACEUTICALS INC.
Reel/Frame 021266/0524 →